- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Humanised anti-IL-6 receptor monoclonal antibody
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Humanised anti-IL-6 receptor monoclonal antibody
| EU orphan designation number: | EU/3/16/1680
|
| Active ingredient: | Humanised anti-IL-6 receptor monoclonal antibody |
| Indication: | Treatment of neuromyelitis optica spectrum disorders |
| Sponsor: | Chugai Pharma Europe Ltd
Mulliner House, Flanders Road, Turnham Green, London, W4 1NN, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 29/06/2016 | Orphan designation | EMA/OD/014/16 | (2016)4121 of 27/06/2016 |
CONTACT
EU links
Directorate General Health & Consumers